GB Sciences will soon start human testing of three cannabis-derived formulations for Parkinson's, chronic pain and cardiovascular diseases.

A proof-of-concept study suggests that combines AI and the whole-genome sequencing of tumors could scale precision medicine for cancer.

The FDA and its new Trump-picked commissioner Scott Gottlieb took to social media to talk up plans to speed up the drug regulation process.

Neuroscience-focused digital technology company Ixico just nabbed a contract for imaging clinical trial services from Spanish biotech Araclon.

INC says it is focused on growing its Asia presence with moves and an expansion.

Parexel has become the latest CRO to be bought up as the industry continues its M&A bonanza.

LabConnect has received a healthy $24.5 million in its first equity investment.

Probably hoping to help turn things around after clinical setbacks, microRNA biotech Regulus tapped the help of CRO Aptuit.

R&D